Rotterdam

• Non-inferiority study of GSK3511294 (depemokimab) compared with mepolizumab or benralizumab in participants with severe asthma with an eosin … Ended
  2023-510230-84-00 5 2021-05-28 Severe asthma with an eosinophilic phenotype
• A Phase 1b Study of AMG 757 in Subjects with Neuroendocrine Prostate Cancer Ended
  2024-513316-10-00 3 2021-04-20 Adult subjects with de novo or treatment-emergent neuroendocrine prost
• Phase 2 Study of DS-1062a in Advanced or Metastatic Non-small Cell Lung Cancer with Actionable Genomic Alterations Ended
  2024-511449-21-00 4 2021-03-25 Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC)
• Dose Escalation of DF1001 in Patients With Advanced Solid Tumors, and Expansion in Selected Indications Ended
  2023-503291-24-00 9 2021-03-17 Locally Advanced or Metastatic Solid Tumors, and Expansion in Selected
• A Multicentre, Open-Label, Single Ascending Dose, Dose-Ranging, Phase I/IIa Study to Evaluate the Safety and Tolerability of an Autologous A … Ended
  2024-512579-11-00 7 2021-03-17 Prophylaxis against renal transplant rejection
• A Phase 3 Study to Evaluate the Efficacy and Safety of Darvadstrocel in the Treatment of Complex Perianal Fistula in Pediatric Subjects with … Ended
  2023-503973-39-00 5 2021-03-16 Complex Perianal Fistulas in Crohn's Disease
• Epitope open-label extension study to evaluate the long-term clinical benefit and safety of DBV712 in peanut-allergic children (EPOPEX) Ended
  2024-515703-19-00 5 2021-03-02 Peanut allergy
• Safety and efficacy of adding immunotherapy combined with stereotactic radiotherapy in patients with limited metastatic pancreatic cancer (M … Ended
  2024-514598-23-00 9 2021-02-09 Limited metastatic pancreatic cancer
• A Phase I/IIb extension study assessing the long-term safety and efficacy of a gene therapy (AAV5-hFIX) previously administered to adult pat … Ended
  2024-512603-39-00 7 2021-01-08 Haemophilia B
• Investigation the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of RO7248824 in Participants with Angelman Syndrome Ended
  2024-514797-45-00 3 2020-08-25 Angelman Syndrome (AS)
• Study to evaluate the addition of an experimental drug, CC-90010, to the usual treatment of brain cancer after surgery Ended
  2024-511171-15-00 3 2020-07-06 Subjects with newly diagnosed WHO Grade IV glioblastoma (ndGBM) who ha
• A Phase 3 Study to Evaluate Efficacy and Safety of AL001 in Frontotemporal Dementia (INFRONT-3) Ended
  2023-506873-36-00 5 2020-06-29 Frontotemporal dementia (FTD)
• A Study of Tirzepatide (LY3298176) Compared With Dulaglutide on Major Cardiovascular Events in Participants With Type 2 Diabetes (SURPASS-CV … Ended
  2023-507846-96-00 5 2020-06-19 Type 2 Diabetes Mellitus
• Double-blinded (treatment group unknown to physician and patient), randomised (treatment group allocated by chance) phase II trial on the ef … Ended
  2023-507897-42-00 4 2020-05-12 Prevention of oesophageal strictures in adult patients after endoscopi
• A Study to Evaluate Safety and Anti-Tumor Activity of RO7284755 Alone or in Combination with Atezolizumab in Participants with Advanced and/ … Ended
  2023-503749-76-00 1 2020-03-06 Solid Tumors
• Phase 1 Study of UniCAR02-T-CD123 in Patients With Selected CD123 Positive Hematologic Malignancies Ended
  2024-515827-12-00 1 2020-01-28 Acute Myeloid Leukemia (AML)
• Medical-scientific research into a new own skin graft product (EHSG-KF) Ended
  2024-512188-29-00 4 2020-01-20 Adults and adolescents with partial deep dermal and full thickness bur
• Botulinum toxin (BOTOX®) to prevent post-operative pancreatic fistula in patients who undergo distal pancreatectomy Ended
  2024-517267-23-00 7 2019-11-11 postoperative pancreatic fistulas
• Pembrolizumab or Placebo Plus Gemcitabine/Cisplatin for First-Line Advanced Ended
  2023-506657-38-00 5 2019-10-02 Biliary Tract Carcinoma
• FUnctional selection of advanced breast cancer patients for Talazoparib treatment Using the REpair Capacity (RECAP) test: The FUTURE trial Ended
  2024-518036-36-03 6 2019-09-20 Breast cancer
• A Long-term Safety Extension Study of Mavacamten (MYK-461) in Adults with Hypertrophic Cardiomyopathy Who Have Completed the MAVERICKHCM (MY … Ended
  2022-502858-14-00 5 2019-09-05 Hypertrophic cardiomyopathy
• Phase 3 Study of Pembrolizumab plus Enzalutamide in mCRPC Ended
  2022-500785-10-00 5 2019-08-23 Metastatic Castration-Resistant Prostate Cancer
• NeoRay - Phase I/IIa trial of [177Lu]-NeoB in patients with advanced solid tumors and with [68Ga]-NeoB lesion uptake. Ended
  2023-507170-41-00 7 2019-07-29 Solid tumors known to overexpress GRPR and with [68Ga]-NeoB lesion upt
• OPTIMIZE Ended
  2024-516509-22-00 6 2019-07-22 kidney transplant

Showing 769–792 of 818 trials